Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research
Industry Leader

Industry Leader

With extensive experience, Creative Biolabs aims to offer you the best in the field of antibody

Read more
De Novo Antibody Sequencing

De Novo Antibody Sequencing

Antibody Sequencing Service Supports Your Antibody Engineering with All-around Service System.

Read more
Global Market

Global Market

Creative Biolabs serves customers from the USA, Canada, European countries and more

Read more
Single Domain Antibody

Single Domain Antibody

Single domain antibody—the most promising antibody in disease diagnosis, genetic modification and more

Read more

Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

February 6, 2021Antibody Engineering Research, Immunotherapy ResearchAntibody Discovery, COVID-19, single domain antibodybiolabs

In a new study, an international team led by the University of Bonn identified and further developed the novel single-domain antibodies (sdAbs) against SARS-CoV-2. The researchers also combined these single-domain antibodies intoRead More…

Nat Methods: How to Enhance the Effect of T Cell Therapy?

January 8, 2021Immunotherapy Researchimmunotherapy, T cell receptorbiolabs

In a recent study, the scientists at UT Southwestern have developed a new method to study the molecular characteristics of T cells. The method, published on Nature Methods, makes it easier forRead More…

New TCR Therapy—Tebentafusp

December 10, 2020Immunotherapy Research, Newstcr, Therapeutic Antibodybiolabs

Recently, the phase 3 clinical trial results of T cell receptor (TCR) therapy, tebentafusp, have been released. The results showed that it reached the primary endpoint in the treatment of metastatic uvealRead More…

eLife: The New Anticancer Mechanism of T Cells

November 3, 2020Immunotherapy ResearchCAR-T, immunotherapybiolabs

A new study published on eLife shows when T cells in the immune system find and identify targets, they release chemicals to attract more T cells, and then gather to help suppressRead More…

The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine

October 12, 2020NewsHepatitis C Virus, nobel prize, virusbiolabs

The 2020 Nobel Prize in Physiology or Medicine is awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus”. Thanks to their discovery,Read More…

COVID-19 May Lead to the Loss of Important Immune Structure—It Is Expected to Explain the Cause of Secondary Infection in Recovered Patients

September 2, 2020Biological Knowledge, NewsCOVID-19, Immune Response, virusbiolabs

According to the latest report from the Science, four research institutions, including Massachusetts Institute of Technology and Harvard University, conducted an autopsy analysis on patients who died of COVID-19 and found thatRead More…

What Are the Development Prospects & Anticancer Potential of CD38 Antibodies?

August 23, 2020Drug Discovery Research, Immunotherapy Researchimmunotherapy, monoclonal antibody, Therapeutic Antibodybiolabs

CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…

Cell: Isolated Strong SARS-CoV-2 Neutralizing Antibody from Patients with COVID-19

July 13, 2020Drug Discovery Research, NewsAntibody Discovery, COVID-19biolabs

An important line of defense against novel coronavirus SARS-CoV-2 is the formation of neutralizing antibodies. These antibodies can eliminate invaders and have great potential in the prevention and treatment of SARS-CoV-2 infection.Read More…

Nature: Major Discovery! A Human Antibody Can Strongly Neutralize A Variety of Coronaviruses, including SARS-CoV and SARS-CoV-2

June 2, 2020Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, COVID-19, SARS-CoV-2biolabs

In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…

Big News! Microbes Control the Health of the Immune System!

May 14, 2020Biological Knowledge, Immunotherapy Research, NewsConventional Dendriticcells, Immune System, immunotherapybiolabs

Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…

Posts navigation

  • 1
  • 2
  • 3
  • …
  • 14
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape
  • Nat Methods: How to Enhance the Effect of T Cell Therapy?
  • New TCR Therapy—Tebentafusp
  • eLife: The New Anticancer Mechanism of T Cells
  • The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine

Archives

Contact Us

USA:
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
Europe:
Tel: 44-207-097-1828

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext